Dual checkpoint inhibitor-associated eosinophilic enteritis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-11-15

AUTHORS

J. Yang, S. M. Lagana, Y. M. Saenger, R. D. Carvajal

ABSTRACT

BackgroundEosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events.Case presentationWe report a case of dual checkpoint inhibitor-associated hypereosinophilia and eosinophilic enteritis in a patient with advanced cutaneous melanoma. Rapid resolution of peripheral eosinophilia and associated symptoms was achieved with steroids alone.ConclusionsImmune checkpoint inhibition can trigger inflammation in virtually any organ in the body, leading to diverse clinical manifestations. To our knowledge, this is the first case report of eosinophilic enteritis due to ipilimumab plus nivolumab. More... »

PAGES

310

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40425-019-0743-5

DOI

http://dx.doi.org/10.1186/s40425-019-0743-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1122629599

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31730503


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Immunological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enteritis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Eosinophilia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastritis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ipilimumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nivolumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "J.", 
        "id": "sg:person.012577717744.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012577717744.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.239585.0", 
          "name": [
            "Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lagana", 
        "givenName": "S. M.", 
        "id": "sg:person.01154322542.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154322542.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.516091.a", 
          "name": [
            "Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA", 
            "Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saenger", 
        "givenName": "Y. M.", 
        "id": "sg:person.0657442276.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657442276.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.516091.a", 
          "name": [
            "Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA", 
            "Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carvajal", 
        "givenName": "R. D.", 
        "id": "sg:person.0726366600.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726366600.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s40800-018-0078-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101526240", 
          "https://doi.org/10.1007/s40800-018-0078-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11894-018-0645-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105250529", 
          "https://doi.org/10.1007/s11894-018-0645-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ni.3159", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029035455", 
          "https://doi.org/10.1038/ni.3159"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.2010.221", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002801339", 
          "https://doi.org/10.1038/modpathol.2010.221"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-11-15", 
    "datePublishedReg": "2019-11-15", 
    "description": "BackgroundEosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events.Case presentationWe report a case of dual checkpoint inhibitor-associated hypereosinophilia and eosinophilic enteritis in a patient with advanced cutaneous melanoma. Rapid resolution of peripheral eosinophilia and associated symptoms was achieved with steroids alone.ConclusionsImmune checkpoint inhibition can trigger inflammation in virtually any organ in the body, leading to diverse clinical manifestations. To our knowledge, this is the first case report of eosinophilic enteritis due to ipilimumab plus nivolumab.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s40425-019-0743-5", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438793", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1049249", 
        "issn": [
          "2051-1426"
        ], 
        "name": "Journal for ImmunoTherapy of Cancer", 
        "publisher": "BMJ", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "eosinophilic enteritis", 
      "checkpoint inhibition", 
      "immune-related adverse events", 
      "immune checkpoint inhibition", 
      "advanced cutaneous melanoma", 
      "first case report", 
      "improved treatment response", 
      "peripheral eosinophilia", 
      "adverse events", 
      "Case presentationWe", 
      "clinical manifestations", 
      "cutaneous melanoma", 
      "case report", 
      "treatment response", 
      "rapid resolution", 
      "new biological effects", 
      "enteritis", 
      "biological effects", 
      "inhibition", 
      "nivolumab", 
      "hypereosinophilia", 
      "eosinophilia", 
      "patients", 
      "inflammation", 
      "melanoma", 
      "symptoms", 
      "steroids", 
      "manifestations", 
      "organs", 
      "report", 
      "response", 
      "cases", 
      "events", 
      "effect", 
      "body", 
      "development", 
      "knowledge", 
      "resolution"
    ], 
    "name": "Dual checkpoint inhibitor-associated eosinophilic enteritis", 
    "pagination": "310", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1122629599"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40425-019-0743-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31730503"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40425-019-0743-5", 
      "https://app.dimensions.ai/details/publication/pub.1122629599"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_825.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s40425-019-0743-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0743-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0743-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0743-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0743-5'


 

This table displays all metadata directly associated to this object as RDF triples.

196 TRIPLES      21 PREDICATES      80 URIs      68 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40425-019-0743-5 schema:about N0157243950fe4dd788407532701ca312
2 N171a209622b24346aac28ae8badac6ef
3 N1aadf351c2e0430cb965a06575a04cd0
4 N20c6823657c6428da58664e74d849f57
5 N33b83252ecbe45dfae6cf9a8db194756
6 N418b7ce7bcd14582bec163e33620d6a0
7 N563d4a1bd88944ebb94140b616fd7a8e
8 N822f2c8160f44ffa80774082ec2af33a
9 Na391c44196cd4d7b819dfb08c83277df
10 Na95a98558ca1441f8ba5cddab2e39149
11 Nab58d9fc756d4ccc8fc8b1a2a0b10d5b
12 Nae46ebd53fa4457a804a354707b66a82
13 Nc2d8c38d1deb4a329a0d4529f8330b2b
14 anzsrc-for:11
15 anzsrc-for:1107
16 schema:author N1e529ead5f9b4a64a7566bf59cec2b84
17 schema:citation sg:pub.10.1007/s11894-018-0645-6
18 sg:pub.10.1007/s40800-018-0078-z
19 sg:pub.10.1038/modpathol.2010.221
20 sg:pub.10.1038/ni.3159
21 schema:datePublished 2019-11-15
22 schema:datePublishedReg 2019-11-15
23 schema:description BackgroundEosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events.Case presentationWe report a case of dual checkpoint inhibitor-associated hypereosinophilia and eosinophilic enteritis in a patient with advanced cutaneous melanoma. Rapid resolution of peripheral eosinophilia and associated symptoms was achieved with steroids alone.ConclusionsImmune checkpoint inhibition can trigger inflammation in virtually any organ in the body, leading to diverse clinical manifestations. To our knowledge, this is the first case report of eosinophilic enteritis due to ipilimumab plus nivolumab.
24 schema:genre article
25 schema:isAccessibleForFree true
26 schema:isPartOf N1504e405d4d443bfb85fd8960f80f1f1
27 N770c568ea6a74d72a7e4da0f30d59e99
28 sg:journal.1049249
29 schema:keywords Case presentationWe
30 advanced cutaneous melanoma
31 adverse events
32 biological effects
33 body
34 case report
35 cases
36 checkpoint inhibition
37 clinical manifestations
38 cutaneous melanoma
39 development
40 effect
41 enteritis
42 eosinophilia
43 eosinophilic enteritis
44 events
45 first case report
46 hypereosinophilia
47 immune checkpoint inhibition
48 immune-related adverse events
49 improved treatment response
50 inflammation
51 inhibition
52 knowledge
53 manifestations
54 melanoma
55 new biological effects
56 nivolumab
57 organs
58 patients
59 peripheral eosinophilia
60 rapid resolution
61 report
62 resolution
63 response
64 steroids
65 symptoms
66 treatment response
67 schema:name Dual checkpoint inhibitor-associated eosinophilic enteritis
68 schema:pagination 310
69 schema:productId N8db392e335a443a698b953339d8d6397
70 Nb0abe4efce8f45ed901c89495a660de9
71 Nec1f6c0dbb634ad5b322d6701977417d
72 schema:sameAs https://app.dimensions.ai/details/publication/pub.1122629599
73 https://doi.org/10.1186/s40425-019-0743-5
74 schema:sdDatePublished 2022-12-01T06:39
75 schema:sdLicense https://scigraph.springernature.com/explorer/license/
76 schema:sdPublisher Neebf9fd0e0694b72b6f2568f17740a5a
77 schema:url https://doi.org/10.1186/s40425-019-0743-5
78 sgo:license sg:explorer/license/
79 sgo:sdDataset articles
80 rdf:type schema:ScholarlyArticle
81 N0157243950fe4dd788407532701ca312 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Ipilimumab
83 rdf:type schema:DefinedTerm
84 N1504e405d4d443bfb85fd8960f80f1f1 schema:volumeNumber 7
85 rdf:type schema:PublicationVolume
86 N171a209622b24346aac28ae8badac6ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Skin Neoplasms
88 rdf:type schema:DefinedTerm
89 N1aadf351c2e0430cb965a06575a04cd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Enteritis
91 rdf:type schema:DefinedTerm
92 N1e529ead5f9b4a64a7566bf59cec2b84 rdf:first sg:person.012577717744.21
93 rdf:rest N64bebd1539c14916836a42e87584cfc7
94 N20c6823657c6428da58664e74d849f57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Eosinophilia
96 rdf:type schema:DefinedTerm
97 N33b83252ecbe45dfae6cf9a8db194756 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Nivolumab
99 rdf:type schema:DefinedTerm
100 N418b7ce7bcd14582bec163e33620d6a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Prednisone
102 rdf:type schema:DefinedTerm
103 N502424da951f4ec58be1937e5fc793ec rdf:first sg:person.0657442276.54
104 rdf:rest Nddb2ee37493245b5a5fdef5df29fbd10
105 N563d4a1bd88944ebb94140b616fd7a8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Gastritis
107 rdf:type schema:DefinedTerm
108 N64bebd1539c14916836a42e87584cfc7 rdf:first sg:person.01154322542.34
109 rdf:rest N502424da951f4ec58be1937e5fc793ec
110 N770c568ea6a74d72a7e4da0f30d59e99 schema:issueNumber 1
111 rdf:type schema:PublicationIssue
112 N822f2c8160f44ffa80774082ec2af33a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Male
114 rdf:type schema:DefinedTerm
115 N8db392e335a443a698b953339d8d6397 schema:name pubmed_id
116 schema:value 31730503
117 rdf:type schema:PropertyValue
118 Na391c44196cd4d7b819dfb08c83277df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Antineoplastic Combined Chemotherapy Protocols
120 rdf:type schema:DefinedTerm
121 Na95a98558ca1441f8ba5cddab2e39149 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Melanoma
123 rdf:type schema:DefinedTerm
124 Nab58d9fc756d4ccc8fc8b1a2a0b10d5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Humans
126 rdf:type schema:DefinedTerm
127 Nae46ebd53fa4457a804a354707b66a82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Antineoplastic Agents, Immunological
129 rdf:type schema:DefinedTerm
130 Nb0abe4efce8f45ed901c89495a660de9 schema:name doi
131 schema:value 10.1186/s40425-019-0743-5
132 rdf:type schema:PropertyValue
133 Nc2d8c38d1deb4a329a0d4529f8330b2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Aged
135 rdf:type schema:DefinedTerm
136 Nddb2ee37493245b5a5fdef5df29fbd10 rdf:first sg:person.0726366600.25
137 rdf:rest rdf:nil
138 Nec1f6c0dbb634ad5b322d6701977417d schema:name dimensions_id
139 schema:value pub.1122629599
140 rdf:type schema:PropertyValue
141 Neebf9fd0e0694b72b6f2568f17740a5a schema:name Springer Nature - SN SciGraph project
142 rdf:type schema:Organization
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
147 schema:name Immunology
148 rdf:type schema:DefinedTerm
149 sg:grant.2438793 http://pending.schema.org/fundedItem sg:pub.10.1186/s40425-019-0743-5
150 rdf:type schema:MonetaryGrant
151 sg:journal.1049249 schema:issn 2051-1426
152 schema:name Journal for ImmunoTherapy of Cancer
153 schema:publisher BMJ
154 rdf:type schema:Periodical
155 sg:person.01154322542.34 schema:affiliation grid-institutes:grid.239585.0
156 schema:familyName Lagana
157 schema:givenName S. M.
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154322542.34
159 rdf:type schema:Person
160 sg:person.012577717744.21 schema:affiliation grid-institutes:grid.51462.34
161 schema:familyName Yang
162 schema:givenName J.
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012577717744.21
164 rdf:type schema:Person
165 sg:person.0657442276.54 schema:affiliation grid-institutes:grid.516091.a
166 schema:familyName Saenger
167 schema:givenName Y. M.
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657442276.54
169 rdf:type schema:Person
170 sg:person.0726366600.25 schema:affiliation grid-institutes:grid.516091.a
171 schema:familyName Carvajal
172 schema:givenName R. D.
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726366600.25
174 rdf:type schema:Person
175 sg:pub.10.1007/s11894-018-0645-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105250529
176 https://doi.org/10.1007/s11894-018-0645-6
177 rdf:type schema:CreativeWork
178 sg:pub.10.1007/s40800-018-0078-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1101526240
179 https://doi.org/10.1007/s40800-018-0078-z
180 rdf:type schema:CreativeWork
181 sg:pub.10.1038/modpathol.2010.221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002801339
182 https://doi.org/10.1038/modpathol.2010.221
183 rdf:type schema:CreativeWork
184 sg:pub.10.1038/ni.3159 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029035455
185 https://doi.org/10.1038/ni.3159
186 rdf:type schema:CreativeWork
187 grid-institutes:grid.239585.0 schema:alternateName Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA
188 schema:name Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA
189 rdf:type schema:Organization
190 grid-institutes:grid.51462.34 schema:alternateName Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
191 schema:name Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
192 rdf:type schema:Organization
193 grid-institutes:grid.516091.a schema:alternateName Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA
194 schema:name Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
195 Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA
196 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...